Skip to main content
NYRADA INC. logo

NYRADA INC. — Investor Relations & Filings

Ticker · NYR ISIN · AU0000070195 ASX Professional, scientific and technical activities
Open in API
Filings indexed 472 across all filing types
Latest filing 2025-01-22 Director's Dealing
Country AU Australia
Listing ASX NYR

About NYRADA INC.

https://www.nyrada.com

Nyrada Inc. specializes in the development of novel small molecule therapeutic agents designed to address unmet needs in cardiovascular health and neuroprotection. The company’s lead programs include a cholesterol-lowering treatment and a neuroprotective treatment for brain injury. The cardiovascular program focuses on an oral PCSK9 inhibitor aimed at managing low-density lipoprotein (LDL) cholesterol levels as an alternative to injectable biologics. The neuroprotection program involves the development of NYR-BI03, a first-in-class small molecule designed to mitigate secondary brain damage following a stroke or traumatic brain injury by targeting canonical transient receptor potential (TRPC) ion channels. These efforts aim to provide effective, accessible pharmacological interventions for both chronic metabolic conditions and acute neurological trauma.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - JM 2 pages 6.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of securities held, disposed, and nature of changes such as lapsing of options. The document is a formal notification of insider share transactions by a director. It does not contain financial statements, earnings data, or management discussion. The content matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 4116 characters, consistent with a notice rather than a full report. Therefore, the correct classification is DIRS (Director's Dealing).
2025-01-22 English
Quarterly Activities Report and Appendix 4C 9 pages 564.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Nyrada Quarterly Activities Report & Appendix 4C' and includes detailed financial data such as cash flow statements, cash position, and financing activities for the quarter ending 31 December 2024. It also discusses operational highlights, clinical trial progress, and corporate updates. The presence of the Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules, confirms this is a quarterly report. The document contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not merely an announcement or a certification, but a comprehensive report including financial statements and operational updates for the quarter. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q4 2024
2025-01-22 English
Change of Director's Interest Notice - CC 2 pages 6.3KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of securities held before and after the change, nature of the change, and related contract information. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades or director dealings. It does not contain financial performance data, management discussion, or other report types. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 4581 characters, which is consistent with a detailed director's dealing notice. Confidence is high due to clear identification of director share transactions and regulatory references specific to director interest notices.
2025-01-21 English
Change of Director's Interest Notice - RW 3 pages 7.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of securities held before and after the change, nature of the change (e.g., lapsing of options), and dates of changes. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 4633 characters, which is consistent with a detailed director's interest notice rather than a brief announcement or a full report. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-01-21 English
Change of Director's Interest Notice - MF 2 pages 6.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director's Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of securities held before and after the change, nature of the change, and dates. This is a clear report of personal share transactions by a company director. The document length is 4432 characters, which is consistent with a detailed director's dealing notice. There is no indication that this is a full financial report, audit, or other type of filing. Therefore, the document fits the definition of Director's Dealing (DIRS).
2025-01-21 English
Notification of cessation of securities - NYR 5 pages 18.4KB
Regulatory Filings Classification · 100% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (expiry or lapse) of various securities such as performance shares and options for NYRADA INC. It includes specific dates of cessation, reasons for cessation, and the impact on issued capital. This is a formal announcement to the ASX about changes in the company's securities status, specifically the cessation of certain securities. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about securities ceasing to exist or lapsing. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-01-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.